Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one is a synthetic organic compound belonging to the pyridazinone class. While pyridazinone derivatives are known for a wide range of biological activities, including potential antidiabetic, anticancer, anti-AIDS, cardiovascular, anti-inflammatory, and anticonvulsant effects, specific pharmaceutical drug development information, such as a defined mechanism of action, primary indication, or clinical trial status for human therapeutic use, is not readily available for this particular compound. It is listed as a pharmaceutical in databases like ZINC15, suggesting its potential as a drug candidate or research chemical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one.